Institutional investors purchased a net $1.5 million shares of MORF during the quarter ended March 2019. This may signal that the smart money is gaining interest in this company as the 60.00% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
DANSKE BANK A/S (INVESTMENT MANA... Sold 121.00 shares of Morphic Holding Inc
STATE TEACHERS RETIREMENT SYSTEM... Sold 200.00 shares of Morphic Holding Inc